Coagulation Factors
Coagulation factors are protein components of the blood which serve blood coagulation.
Search results 1 to 25 from a total of 82
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|---|---|---|---|
|
ADVATE |
Baxter AG, Wien |
EU/1/03/271/001-020 | 02.03.2004 | |
|
Adynovi |
Baxalta Innovations GmbH, A |
EU/1/17/1247 | 08.01.2018 | |
|
Afstyla |
CSL Behring GmbH |
EU/1/16/1158 | 04.01.2017 | |
|
Alphanine 500 |
Grifols Deutschland GmbH |
6408.00.00 | 17.07.1985 | |
|
Alphanine 1000 |
Grifols Deutschland GmbH |
6408.01.00 | 17.07.1985 | |
|
Alprolix |
Swedish Orphan Biovitrum AB (publ) |
EU/1/16/1098 | 12.05.2016 | |
|
BeneFIX |
Pfizer Limited, UK |
EU/1/97/047/004-008 | 27.08.1997 | |
|
Beriate 250 |
CSL Behring GmbH |
10505a/98-1 | 11.02.1998 | Rote-Hand-Brief: Beriate (09.08.2019) |
|
Beriate 500 |
CSL Behring GmbH |
10505a/98-2 | 11.02.1998 | Rote-Hand-Brief: Beriate (09.08.2019) |
|
Beriate 1000 |
CSL Behring GmbH |
10505a/98-3 | 11.02.1998 | Rote-Hand-Brief: Beriate (09.08.2019) |
|
Beriate 2000 |
CSL Behring GmbH |
10505a/98-4 | 11.12.2012 | Rote-Hand-Brief: Beriate (09.08.2019) |
|
Berinin P 600 |
CSL Behring GmbH |
6121.01.00 | 15.05.1985 | |
|
Berinin P 1200 |
CSL Behring GmbH |
6121.02.00 | 15.05.1985 | |
|
Beriplex P/N 250 |
CSL Behring GmbH |
10500a/95 | 21.02.1996 | |
|
Beriplex P/N 500 |
CSL Behring GmbH |
10501a/95 | 21.02.1996 | |
|
Beriplex P/N 1000 |
CSL Behring GmbH |
10501a/95a | 26.01.2013 | |
|
Cluvot 250 I.E. |
CSL Behring GmbH |
PEI.H.11666.01.1 | 07.03.2014 | |
|
Cluvot 1250 I.E. |
CSL Behring GmbH |
PEI.H.11666.02.1 | 07.03.2014 | |
|
Coagadex |
Bio Products Laboratory Ltd., UK-Hertfordshire |
EU/1/16/1087 | 16.03.2016 | |
|
Cofact 500 |
Sanquin, NL - Amsterdam |
PEI.H.03453.02.1 | 31.08.2007 | |
|
Elocta |
Swedish Orphan Biovitrum AB (publ) |
EU/1/15/1046 | 19.11.2015 | |
Esperoct |
Novo Nordisk A/S, Dänemark |
EU/1/19/1374 | 20.06.2019 | |
|
Faktor VIII SDH INTERSERO 250 |
Intersero GmbH |
16844.00.00 | 06.11.1991 | |
|
Faktor VIII SDH INTERSERO 500 |
Intersero GmbH |
16844.01.00 | 06.11.1991 | |
|
Faktor VIII SDH INTERSERO 1000 |
Intersero GmbH |
16844.02.00 | 06.11.1991 |
Hints
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 477 in BAnz AT 16.02.2021 B7.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 16.02.2021
